Eubiotics Market by Type, Livestock, & by Region - Global Trends and Forecast to 2020

The eubiotics market in feed has been growing rapidly in the recent years and is projected to reach a market size at USD 7.05 billion by 2020. The market is primarily driven by the growing customer attention towards superior quality feed grades, ban on antibiotics used as growth promoters in the North American and European regions, and for feed supplementation to improve nutrient utilization and nutrient supply to the animals. The consumption of eubiotics is increasing significantly due to various government regulations being adopted to improve animal health.
Europe held the largest share of the eubiotics market in 2014. Currently, the eubiotics market is concentrated more in developed and developing countries, such as U.S., China, India, Japan, Australia, along with European countries. The growth is mainly due to the global increase in meat consumption and rise in concern regarding its quality and safety. The market for probiotics is projected to grow at the highest CAGR of 7.6% during the period from 2015 to 2020. The probiotics segment also accounted for the largest share of 65.47% in 2014, and is projected to be valued at USD 4.69 billion by 2020.
The eubiotics market is highly competitive with a large number of global market players. This report highlights the growth strategies adopted by the major market players between 2010 and 2015. Key industry players invest extensively in research and development initiatives to expand their product portfolios. Continuous investments in new product development, launches, and expansions have expanded the scope of the industry.
The global market is marked with intense competition due to the presence of a large number of big and small firms. New product developments, mergers & acquisitions, and expansions are the key strategies adopted by market players to ensure their growth. The market is dominated by players such as the Chr. Hansen (Denmark), Cargill Incorporated (U.S.) and ADDCON (Germany), BASF SE (Germany), Kemin Industries Inc. (U.S.), and Behn Meyer (Singapore).
In this report, the global eubiotics market is segmented into type, livestock, and region. The said market was valued at USD 4.62 billion in 2014 and is projected to grow at a CAGR of 7.4% from 2015 to 2020.

1.1 AVAILABLE CUSTOMIZATIONS
With the given market data, MarketsandMarkets offers customizations according to the company’s specific scientific needs.

The following customization options are available for the report:

Product Analysis
‧Product matrix which gives a detailed comparison of product portfolio of each company

Geographic Analysis
‧Further breakdown of the Rest of Asia-Pacific eubiotics market into Malaysia, Thailand, Indonesia, and Vietnam

‧Further breakdown of the Rest of RoW eubiotics market into Argentina, Madagascar, Morocco, Chile, Peru, and Sudan

Company Information
‧Detailed analyses and profiling of additional market players (up to five)

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 15
1.3 STUDY SCOPE 15
1.3.1 YEARS CONSIDERED 16
1.4 CURRENCY CONSIDERED 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key Data from Secondary Sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key Data from Primary Sources 21
2.1.2.2 Key Industry Insights 22
2.1.2.3 Breakdown of Primary Interviews 23
2.2 FACTOR ANALYSIS 23
2.2.1 INTRODUCTION 23
2.2.2 DEMAND-SIDE ANALYSIS 24
2.2.2.1 Growing population and rising diversified food demand 24
2.2.2.2 Emerging Economies: Population & Meat Demand 25
2.2.3 SUPPLY-SIDE ANALYSIS 25
2.2.3.1 Parent Market Analysis: Animal Feed Industry 25
2.3 MARKET SIZE ESTIMATION 26
2.3.1 BOTTOM-UP APPROACH 27
2.3.2 TOP-DOWN APPROACH 28
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 29
2.5 RESEARCH ASSUMPTIONS & LIMITATIONS 30
2.5.1 ASSUMPTIONS 30
2.5.2 LIMITATIONS 31
3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 37
4.1 ATTRACTIVE OPPORTUNITIES IN EUBIOTICS MARKET 37
4.2 PROBIOTICS: LEADING SEGMENT BY TYPE 38
4.3 LEADING MARKET FOR EUBIOTICS 39
4.4 EUROPE: LARGEST EUBIOTICS MARKET 40
4.5 LIFE CYCLE ANALYSIS: BY REGION 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 43
5.1.1 DIFFERENT TYPES OF EUBIOTICS 43
5.1.1.1 Probiotics 43
5.1.1.2 Prebiotics 43
5.1.1.3 Essential oils 43
5.1.1.4 Organic acids 43
5.2 MARKET SEGMENTATION 44
5.2.1 EUBIOTICS MARKET, BY TYPE 44
5.2.2 EUBIOTICS MARKET, BY LIVESTOCK 45
5.3 MARKET DYNAMICS 46
5.3.1 DRIVERS 47
5.3.1.1 Increase in meat production/consumption 47
5.3.1.2 Rising awareness about feed quality 47
5.3.1.3 Increasing disease outbreaks in livestock 48
5.3.1.4 Replacing antibiotic growth promoters (AGP) with eubiotics in feed 48
5.3.2 RESTRAINTS 48
5.3.2.1 Regulatory structure & intervention 48
5.3.3 OPPORTUNITIES 49
5.3.3.1 Investment in research & development 49
5.3.3.2 Exploring regional & untapped markets 49
5.3.4 CHALLENGES 49
5.3.4.1 Rise in Raw Material Prices 49
5.4 REGULATIONS 49
5.4.1 ANTIBITOTICS AS FEED ADDITIVES 49
5.4.2 BAN ON ANTIBIOTICS 50
5.4.2.1 Europe 50
5.4.2.2 South Korea 51
5.4.2.3 U.S. 51
6 INDUSTRY TRENDS 53
6.1 INTRODUCTION 53
6.2 VALUE CHAIN ANALYSIS 53
6.3 SUPPLY CHAIN ANALYSIS 55
6.3.1 PROMINENT COMPANIES 55
6.3.2 SMALL & MEDIUM ENTERPRISES 55
6.3.3 END USERS 56
6.4 PORTER’S FIVE FORCES ANALYSIS 56
6.4.1 INTENSITY OF COMPETITIVE RIVALRY 57
6.4.2 BARGAINING POWER OF SUPPLIERS 57
6.4.3 BARGAINING POWER OF BUYERS 58
6.4.4 THREAT OF NEW ENTRANTS 58
6.4.5 THREAT OF SUBSTITUTES 59
6.5 STRATEGIC BENCHMARKING 60
6.5.1 EXPANSIONS & INVESTMENTS 60
7 EUBIOTICS MARKET, BY TYPE 61
7.1 INTRODUCTION 62
7.2 PROBIOTICS 63
7.2.1 LACTOBACILLI 63
7.2.2 BIFIDOBACTERIA 63
7.3 PREBIOTICS 64
7.3.1 INULIN 64
7.3.2 FRUCTOOLIGOSACCHARIDES (FOS) 64
7.3.3 GALACTO-OLIGOSACCHARIDES (GOS) 64
7.4 ESSENTIAL OILS 66
7.5 ORGANIC ACIDS 67
8 EUBIOTICS MARKET, BY LIVESTOCK 68
8.1 INTRODUCTION 69
8.1.1 KEY FEATURES 69
8.1.1.1 Modulation of microflora 69
8.1.1.2 Stimulate the immune response 69
8.1.1.3 Metabolite excretion 69
8.2 SWINE 71
8.2.1 KEY FEATURES 71
8.2.1.1 Prevent, Stimulate, and Neutralize 71
8.2.1.2 Defence against infection 71
8.3 POULTRY 72
8.3.1 KEY FEATURES 73
8.3.1.1 Growth and improved feed conversion rate 73
8.4 RUMINANTS 74
8.5 AQUATIC ANIMALS 75
8.6 EUBIOTICS FOR OTHER LIVESTOCK TYPES 77
9 EUBIOTICS MARKET, BY REGION 78
9.1 INTRODUCTION 79
9.2 NORTH AMERICA 81
9.2.1 U.S. 84
9.2.2 CANADA 86
9.2.3 MEXICO 87
9.3 EUROPE 89
9.3.1 U.K. 92
9.3.2 GERMANY 94
9.3.3 FRANCE 95
9.3.4 ITALY 97
9.3.5 SPAIN 98
9.3.6 RUSSIA 100
9.3.7 SWITZERLAND 102
9.3.8 REST OF EUROPE 103
9.4 ASIA-PACIFIC 105
9.4.1 CHINA 108
9.4.2 INDIA 110
9.4.3 JAPAN 111
9.4.4 AUSTRALIA 113
9.4.5 REST OF ASIA-PACIFIC 115
9.5 REST OF THE WORLD (ROW) 117
9.5.1 BRAZIL 119
9.5.2 ARGENTINA 121
9.5.3 SOUTH AFRICA 123
9.5.4 OTHER COUNTRIES IN ROW 125
10 COMPETITIVE LANDSCAPE 127
10.1 OVERVIEW 127
10.2 EUBIOTICS MARKET: MARKET SHARE ANALYSIS (DEVELOPMENTS) 128
10.3 COMPETITIVE SITUATIONS & TRENDS 129
10.3.1 EXPANSIONS & INVESTMENTS 130
10.3.2 MERGERS & ACQUISITIONS 131
10.3.3 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS 132
10.3.4 NEW PRODUCT LAUNCHES 133
10.3.5 INNOVATION 133

11 COMPANY PROFILES 134
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
11.1 INTRODUCTION 134
11.2 CHR. HANSEN A/S 135
11.3 ROYAL DSM 139
11.4 E. I. DU PONT DE NEMOURS AND COMPANY 143
11.5 CARGILL INCORPORATED 146
11.6 KEMIN INDUSTRIES INC. 149
11.7 BASF SE 152
11.8 BEHN MEYER GROUP 156
11.9 BENEO GROUP 158
11.10 NOVUS INTERNATIONAL, INC. 159
11.11 ADDCON 161
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.
12 APPENDIX 163
12.1 INSIGHTS OF INDUSTRY EXPERTS 163
12.2 DISCUSSION GUIDE 164
12.3 COMPANY DEVELOPMENTS 167
12.3.1 NEW PRODUCT LAUNCHES/DEVELOPMENTS 167
12.3.2 MERGERS & ACQUISITIONS 168
12.3.3 EXPANSIONS & INVESTMENTS 169
12.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 170
12.5 AVAILABLE CUSTOMIZATIONS 170
12.6 RELATED REPORTS 171